Voltar
Editorial Acesso aberto Revisado por pares
BIBTEX RIS

Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome

2020; European Respiratory Society; Volume: 56; Issue: 4 Linguagem: Inglês

10.1183/13993003.03006-2020

ISSN

1399-3003

Autores

Luke Y. C. Chen, Ryan L. Hoiland, Sophie Stukas, Cheryl L. Wellington, Mypinder S. Sekhon,

Tópico(s)

Immune Cell Function and Interaction

Resumo

Hypercytokinaemic immune dysregulation in COVID-19 is known as cytokine storm syndrome. Interleukin-6 levels ≥80 pg·mL −1 predict an increased risk of respiratory failure and death, and immunomodulatory therapy is an area of urgent investigation. https://bit.ly/3jq3uJ4

Referência(s)